SINEQUAN Drug Patent Profile
✉ Email this page to a colleague
When do Sinequan patents expire, and when can generic versions of Sinequan launch?
Sinequan is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in SINEQUAN is doxepin hydrochloride. There are seven drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sinequan
A generic version of SINEQUAN was approved as doxepin hydrochloride by MYLAN PHARMS INC on May 13th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SINEQUAN?
- What are the global sales for SINEQUAN?
- What is Average Wholesale Price for SINEQUAN?
Summary for SINEQUAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,822 |
| DailyMed Link: | SINEQUAN at DailyMed |
Recent Clinical Trials for SINEQUAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Balamand | Phase 4 |
| Mayo Clinic | Phase 2 |
| National Cancer Institute (NCI) | Phase 2 |
US Patents and Regulatory Information for SINEQUAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | SINEQUAN | doxepin hydrochloride | CONCENTRATE;ORAL | 017516-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-007 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SINEQUAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-006 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-005 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | SINEQUAN | doxepin hydrochloride | CONCENTRATE;ORAL | 017516-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-007 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
